Stoxline.com

Stoxline Lite

Stoxline Pro

Option Calculator
 

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations | Forex | Stock Talks | Blogs | Newsletter

 

Click to view technical analysis chart 

Free Download
Stoxline Android App

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

235.77

Shares Float (M)

234.36

% Held by Insiders

0.78

% Held by Institutions

92.70

Shares Short (K)

6130

Shares Short Prior Month (K)

5310

Stock Basics & Statistics

EPS

-1.980

EPS Est. Current Year

-2.240

EPS Est. Next Year

0.740

EPS Est. Next Quarter

-0.630

Forward EPS

Book Value (p.s.)

5.800

PEG Ratio

-1.51

Profit Margin

-36.72

Operating Margin

-16.45

Return on Assets (ttm)

-4.9

Return on Equity (ttm)

-53.1

Qtrly Rev. Growth

5.1

Gross Profit (p.s.)

4.581

Sales Per Share

5.132

EBITDA (p.s.)

-0.643

Qtrly Earnings Growth

Operating Cash Flow (M)

-51.57

Levered Free Cash Flow (M)

98.25

Valuation

P/E

-33.42

P/E Growth Ratio

-0.01

P/BV

11.41

P/S

12.90

P/CF

-302.56

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

2

Download Stock Research Reports

Subscribe to newsletters (free)

- Top Stock Picks, two picks per email. (one to three emails per week.)

- Weekly Showcase Stocks, two stocks per email. (one email per week.)

 

Enter Stock Symbol:  

Vertex Pharmaceuticals Inc (VRTX)

66.18 -0.74 (-1.11%)

4/24/2014  4:00pm

Open:

66.96

Pre. Close:

66.92

High:

67.49

Low:

64.05

Volume:

1,204,660

Market Cap:

15.603B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

68.16 - 69.05

69.05 - 69.73

Low:

62.11 - 63.05

63.05 - 63.77

Close:

65.04 - 66.62

66.62 - 67.85

Technical analysis  (as of: 2014-04-24 4:38:20 PM)

Overall:

      

Our rating system posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 83.39     One year: 91.77

Support:

Support1: 59.79    Support2: 49.75

Resistance:

Resistance1: 71.40    Resistance2: 78.57

Pivot:

65.77

Moving Averages:

MA(5): 66.21     MA(20): 67.00

MA(100): 74.80     MA(250): 75.92

MACD:

MACD(12,26): -2.47     Signal(12,26,9): -3.03

%K %D:

%K(14,3): 55.58     %D(3): 51.79

RSI:

RSI(14): 43.17

52-Week:

High: 89.96  Low: 58.06  Change(%): -16.2

Average Vol(K):

3-Month: 1608  10-Days 1666

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
VRTX has closed below upper band by 45.1%. Bollinger Bands are 18.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 11 Apr 2014 23:48:45 GMT
Why Biogen Idec Inc., Vertex Pharmaceuticals Incorporated, and Broadcom Corp ...

Tue, 22 Apr 2014 12:22:30 GMT
Vertex Pharmaceuticals (VRTX) Sees Hammer Chart Pattern: Time to Buy?

Tue, 15 Apr 2014 15:11:15 GMT
Analysts View on Biotech Equities -- Research on Organovo Holdings, BioMarin ...

Fri, 18 Apr 2014 10:41:15 GMT
Investor's Watch List - Pharmacyclics, Inc. (PCYC), Vertex Pharmaceuticals ...

Tue, 22 Apr 2014 12:22:30 GMT
Vertex Pharmaceuticals (VRTX) Sees Hammer Chart Pattern: Time to Buy ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

 

Nova Stocks

Share your ideas ...
Find hot stocks ...

 

(c) 2006-2013 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.